Multifaceted Lung Tissue Model for Tuberculosis
Corresponding Organization : Linköping University
Other organizations : Karolinska Institutet
Variable analysis
- Presence or absence of MMP inhibitor (marimastat) treatment on primary macrophages
- Cytokine and chemokine levels in the supernatant
- Tissue development (mucus secretion and stratification)
- 16HBE cells
- Human primary macrophages (uninfected/infected at MOI 10 with Mtb expressing GFP)
- PKH26 red dye-labeled monocytes
- Collagen-embedded MRC-5 cells
- Air exposure at day 5 post infection
- Positive control: Lung tissue models with primary macrophages treated with the MMP inhibitor marimastat
- Negative control: Lung tissue models with primary macrophages without MMP inhibitor treatment
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!